Company intelligence / Profile preview

ARC Pharmaceuticals

Vancouver, British Columbia, Canadaarc.losrios.edu ↗

Ownership: Private
Development stage: Other

Overview

ARC Pharmaceuticals develops medical products targeting proliferative diseases, with an initial emphasis on preventing surgical adhesions—a major complication in many surgeries. The company holds exclusive IP in this area and also pursues treatments for rheumatoid arthritis, osteoarthritis, and psoriasis. No recent clinical results are publicly summarized; the company remains privately held and focused on R&D.

Therapeutic areas: DermatologyImmunologyRheumatologyOther
Modalities: Not explicitly stated; based on focus, likely includes small molecules and possibly biologics for proliferative diseases
Industry: Biotech

Partnerships

No major partnerships publicly disclosed as of latest data available.

Beyond the preview

Go deeper on ARC Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARC Pharmaceuticals.

Explore the full profile